Pharmacovigilance Market Global Opportunity Analysis and Industry Forecast, 2020–2027

1
Pharmacovigilance Market To Reach USD 11.54
Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary

• According to the current analysis of Reports and
  Data, the global Pharmacovigilance market was
  valued at USD 4.33 billion in 2018 and is
  expected to reach USD 11.54 billion by the year
  2026, at a CAGR of 13.1. The safety concern of
  drug is now becoming the priority area of
  interest all across the world. It has opened the
  eyes of drug regulators as well as another
  regulatory body to establish a way to ensure drug
  safety concerns previously, the issues were in
  shadow. The drug safety issues were globalized,
  strengthen, and systematized after the favorable
  regulatory scenario was established.
  Pharmacovigilance is the field of science and
  activities which is related to the detection,
  assessment, understanding, and prevention of
  adverse effects or any other drug-related
  concern. Therefore, the ultimate goal of this
  activity is to improve the safety and rationalize
  the use of medicines in healthcare, thereby
  improving patient care and public health in the
  healthcare field.

3
Our Approach
Market Summary

• Every drug is associated with beneficial as well
  as an undesirable or adverse effect. Adverse drug
  reactions (ADR) is a common clinical problem. The
  major focus of pharmacovigilance is on ADR and
  drug toxicity. According to the WHO, studies show
  that in developed countries, nearly 5 of
  hospitalized patients are admitted into hospital
  as a result of an ADR, and 6-10 of in-patients
  are expected to experience a serious ADR during
  hospitalization. The pharmacovigilance market
  consists of all types of adverse events reporting
  conducted during clinical trials in hospitals,
  pharmacies, and other healthcare sectors.
  Increasing demand for acceptance and adoption of
  outsourcing services by healthcare companies will
  stimulate pharmacovigilance market growth during
  the forecast period. Moreover, Outsourcing
  eliminates the risk of business overhead costs as
  well as the deployment of pharmacovigilance
  resources.
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /2253

4
Our Approach
Market Summary

• Key takeaways of the Pharmacovigilance market
  report has been enlisted below
• A comprehensive overview of the competitive
  landscape of the Pharmacovigilance market that
  examines the market position of leading companies
  like Accenture, Clinquest Group B.V., Cognizant,
  Laboratory Corporation of America Holdings, IBM
  Corporation, ArisGlobal, ICON plc. Capgemini,
  ITClinical, IMD global, Foresight Group
  International AG, TAKE Solutions Ltd., PAREXEL
  International Corporation, BioClinica, Wipro
  Ltd., and United BioSource Corporation. have been
  studied elaborately in the study.
• A brief description of all manufacturers,
  products range, and product applications have
  been also been provided.
• The report underlines information pertaining to
  the leading organizations based on their market
  positions as well as revenue generated.
• The report also includes the companies reported
  profit margins and pricing structure.

5
Our Approach
Market Summary

• Clinical trial phase (Revenue, USD Million
  20162026)
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
• Service providers (Revenue, USD Million
  20162026)
• In-house
• Contract Outsourcing
• Order Now_at_ https//www.reportsanddata.com/checkout
  -form/2253

6
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com